TP53 and hepatocellular carcinoma: We found that in high risk HCC patients, TP53 (tumor protein p53) showed the highest mutation rate (42%) (Fig. 5 C), while in low risk patients, CTNNB1’s (catenin beta 1) mutation rate 25% was highest (Fig. 5D).